Sign in

CIK 0001651308

  • Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981209416
Phone
+41 616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 4 Open-market sale CFO & Chief Strategy Officer sold 486 shares at $325.89 ($158,383)
  2. 4 Grant or award Director acquired 7,800 shares (grant or award)
  3. 4 Grant or award Director acquired 7,800 shares (grant or award)
  4. 4 Grant or award Director acquired 7,800 shares (grant or award)
  5. 4 Grant or award Director acquired 7,800 shares (grant or award)
  6. 4 Grant or award Director acquired 7,800 shares (grant or award)
  7. 4 Grant or award Director acquired 7,800 shares (grant or award)
  8. 4 Grant or award Director acquired 31,200 shares (grant or award)
  9. 4 Open-market sale Director sold 6,000 shares at an average $351.67 ($2,110,018)
  10. 4 Open-market sale President, COO & GM China sold 3,398 shares at an average $352.54 ($1,197,917)
  11. 4 Open-market sale CFO & Chief Strategy Officer sold 650 shares at $354.16 ($230,203)
  12. 4 Open-market sale Global Head of R&D sold 656 shares at $354.26 ($232,392)
  13. 4 Open-market sale CMO, Hematology sold 603 shares at $351.55 ($211,986)
  14. 4 Gift Director gave 7,400 shares (gift)
  15. 4 Gift Director gave 69,000 shares (gift)
  16. 4 Open-market sale CMO, Hematology sold 2,040 shares at an average $357.98 ($730,281)
  17. 4 Gift Director gave 4,700 shares (gift)
  18. 4 Open-market sale Director sold 3,394 shares at an average $300.46 ($1,019,752)
  19. 4 Open-market sale President, COO & GM China sold 6,715 shares at $343.00 ($2,303,245)
  20. 4 Open-market sale CMO, Hematology sold 1,500 shares at an average $354.92 ($532,387)

Page 16 of 29 · 580 filings